Skip to main content

Loading market data...

HIMS

Hims & Hers Health, Inc.

NYSE • United states

$29.21

+$1.06

(+3.77%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Why it’s moving

Product news

Source: Seeking Alpha • Open • 1 day ago • Verified

Management
Credibility
Score

Hims & Hers Health, Inc. (HIMS)

Unavailable

Quotes may be delayed

$6.82B

Market Cap

10,516,330

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Hims & Hers Health, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 2269 CHESTNUT ST, SAN FRANCISCO, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

8 Oct 2026

Hims & Hers Health, Inc. reported A director or senior management change or compensation event

Hims & Hers Health, Inc. filed an 8-K covering a director or senior management change or compensation event.

1 Sep 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Hims & Hers Health, Inc..

11 Aug 2026

Hims & Hers Health, Inc. filed Form 10-Q

Hims & Hers Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

11 Aug 2026

Hims & Hers Health, Inc. reported Operating or financial results

Hims & Hers Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

31 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Hims & Hers Health, Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$609.81M

Total assets (USD)$3.63B

Total liabilities (USD)$3.30B

Shareholders' equity (USD)$324.07M

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$753.21M	−$97.19M	−$86.29M	−$0.37	10-Q · 10 Aug 2026
Q1 2026	$608.10M	−$78.32M	−$92.12M	−$0.40	10-Q · 11 May 2026
Q4 2025	$617.82M	$9.19M	$20.60M	Unavailable	10-K · 23 Feb 2026
Q3 2025	$598.98M	$11.81M	$15.77M	$0.06	10-Q · 3 Nov 2025
Q2 2025	$544.83M	$26.72M	$42.51M	$0.17	10-Q · 4 Aug 2025
Q1 2025	$586.01M	$57.90M	$49.49M	$0.20	10-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $32.82

12.4% upside potential

📈

Strong Buy

Unavailable

👍

Buy

3

⏸️

Hold

11

📉

Sell

0

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 12:48 UTC Targets range 26.00–42.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

14

Oct 2026

Boughton Soleil

Chief Legal Officer

Open-market sale

$29.06 per share

3,461 shares

1

Oct 2026

Okupe Oluyemi

Chief Financial Officer

Open-market sale

$29.70 per share

2,000 shares

30

Sep 2026

Boughton Soleil

Chief Legal Officer

Open-market sale

$29.17 per share

3,461 shares

22

Sep 2026

Okupe Oluyemi

Chief Financial Officer

Option exercise

$5.01 per share

14,000 shares

22

Sep 2026

Okupe Oluyemi

Chief Financial Officer

Open-market sale

$29.95 per share

29,277 shares

17

Sep 2026

Okupe Oluyemi

Chief Financial Officer

Open-market sale

$28.82 per share

12,313 shares

16

Sep 2026

Boughton Soleil

Chief Legal Officer

Open-market sale

$27.86 per share

6,236 shares

15

Sep 2026

Chi Michael

Chief Operating Officer

Open-market sale

$28.39 per share

14,027 shares

15

Sep 2026

Elshenawy Mohamed

CTO

Open-market sale

$28.39 per share

7,954 shares

Top Shareholders

Blackrock, Inc.

28,703,514 shares

8.985% change

6/30/2026

Vanguard Group Inc

20,925,666 shares

7.212% change

12/31/2025

Vanguard Portfolio Management Llc

10,559,314 shares

3.687% change

6/30/2026

Vanguard Capital Management Llc

9,541,384 shares

2.159% change

6/30/2026

State Street Corp

8,145,699 shares

9.191% change

6/30/2026

Morgan Stanley

7,152,498 shares

-19.536% change

6/30/2026

Divisadero Street Capital Management, Lp

6,009,505 shares

1179.073% change

6/30/2026

Geode Capital Management, Llc

5,681,832 shares

9.292% change

6/30/2026

Goldman Sachs Group Inc

5,173,865 shares

110.774% change

6/30/2026

Jpmorgan Chase & Co

4,766,781 shares

-9.045% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 12:48 UTC· 17 hours ago

Research coverage and investment tools

Hims & Hers Health, Inc. (HIMS) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Nursing Services). Its last price was US$29.21 on 20 Oct 2026. That is 42% of the way from its 52-week low of US$13.74 to its 52-week high of US$50.99. Its market capitalisation was US$6.82 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$753.21M	−$97.19M	−$86.29M	−$0.37	63.8%	-12.9%	—	10-Q · 10 Aug 2026 (opens in a new tab)
Q1 2026	$608.10M	−$78.32M	−$92.12M	−$0.40	65.2%	-12.9%	—	10-Q · 11 May 2026 (opens in a new tab)
Q4 2025	$617.82M	$9.19M	$20.60M	Unavailable	71.9%	1.5%	—	10-K · 23 Feb 2026 (opens in a new tab)
Q3 2025	$598.98M	$11.81M	$15.77M	$0.06	73.8%	2.0%	—	10-Q · 3 Nov 2025 (opens in a new tab)
Q2 2025	$544.83M	$26.72M	$42.51M	$0.17	76.4%	4.9%	—	10-Q · 4 Aug 2025 (opens in a new tab)
Q1 2025	$586.01M	$57.90M	$49.49M	$0.20	73.5%	9.9%	—	10-Q · 5 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/10/2026	−$0.10	−$0.07	-42.9%
Mar 2026	5/11/2026	−$0.18	$0.04	-550.0%
Dec 2025	2/23/2026	$0.07	$0.02	+250.0%
Sep 2025	11/3/2025	$0.09	$0.09	0.0%

Cash and equivalents: $609.81M
Total assets: $3.63B
Total liabilities: $3.30B
Shareholders' equity: $324.07M
Debt due within a year: $0

8-K · 8 Oct 2026 · Management change

Hims & Hers Health, Inc. reported A director or senior management change or compensation event (opens in a new tab)

Hims & Hers Health, Inc. filed an 8-K covering a director or senior management change or compensation event.
SCHEDULE 13D/A · 1 Sep 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Hims & Hers Health, Inc..
10-Q · 11 Aug 2026

Hims & Hers Health, Inc. filed Form 10-Q (opens in a new tab)

Hims & Hers Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 11 Aug 2026

Hims & Hers Health, Inc. reported Operating or financial results (opens in a new tab)

Hims & Hers Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
SCHEDULE 13G · 31 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Hims & Hers Health, Inc..

Insider	Date	Transaction	Shares	Average price	Filing
Boughton Soleil Chief Legal Officer	14 Oct 2026	Open-market sale (S)	−3,461	$29.06	Form 4 (opens in a new tab)
Okupe Oluyemi Chief Financial Officer	1 Oct 2026	Open-market sale (S)	−2,000	$29.70	Form 4 (opens in a new tab)
Boughton Soleil Chief Legal Officer	30 Sep 2026	Open-market sale (S)	−3,461	$29.17	Form 4 (opens in a new tab)
Okupe Oluyemi Chief Financial Officer	22 Sep 2026	Option exercise (M)	+14,000	$5.01	Form 4 (opens in a new tab)
Okupe Oluyemi Chief Financial Officer	22 Sep 2026	Open-market sale (S)	−29,277	$29.95	Form 4 (opens in a new tab)
Okupe Oluyemi Chief Financial Officer	17 Sep 2026	Open-market sale (S)	−12,313	$28.82	Form 4 (opens in a new tab)
Boughton Soleil Chief Legal Officer	16 Sep 2026	Open-market sale (S)	−6,236	$27.86	Form 4 (opens in a new tab)
Chi Michael Chief Operating Officer	15 Sep 2026	Open-market sale (S)	−14,027	$28.39	Form 4 (opens in a new tab)
Elshenawy Mohamed CTO	15 Sep 2026	Open-market sale (S)	−7,954	$28.39	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	28,703,514	8.985%
Vanguard Group Inc	12/31/2025	20,925,666	7.212%
Vanguard Portfolio Management Llc	6/30/2026	10,559,314	3.687%
Vanguard Capital Management Llc	6/30/2026	9,541,384	2.159%
State Street Corp	6/30/2026	8,145,699	9.191%
Morgan Stanley	6/30/2026	7,152,498	-19.536%
Divisadero Street Capital Management, Lp	6/30/2026	6,009,505	1179.073%
Geode Capital Management, Llc	6/30/2026	5,681,832	9.292%
Goldman Sachs Group Inc	6/30/2026	5,173,865	110.774%
Jpmorgan Chase & Co	6/30/2026	4,766,781	-9.045%

Previous close: 28.15 USD
Day range: 27.75 – 30.02 USD
52-week range: 13.74 – 50.99 USD
Volume: 10,516,330
Market cap: $6.82B
EPS (FY 2025, diluted): 0.51 USD
Shares outstanding: 233.31M
Beta (5Y monthly): 2.49

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:08 UTC· 25 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for HIMS yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.